Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02801643 · ClinicalTrials.gov registry record
The Impact of Reward-induced Dopamine Release on Functional Connectivity: a Combined PET/fMRI Study
A clinical trial of Healthy, sponsored by Stony Brook University.
- Completed
- Registry status
- 5
- Enrollment target
- 1
- Study location
NCT02801643: Completed study of Healthy, sponsored by Stony Brook University.
NCT02801643 is a study of Healthy that has completed, run by Stony Brook University. The registered enrollment target is 5 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02801643, a study of Healthy, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The present study would be the first to investigate the relationship between reward- and or social stimuli-induced dopamine (DA) release and neural function using a combined PET/fMRI approach. Data from this project conducted in healthy subjects will provide preliminary data for a larger grant application to study patient populations with known abnormalities in DA including schizophrenia, major depressive, substance use, and eating disorders.
Primary Outcome
changes in dopamine receptor binding potential will be measured during and after a reward task or social stimulus task
Conditions Studied
Study Locations (1)
New York
- Health Sciences Center - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2016-06 |
| Est. Completion | 2017-12 |
What the finished NCT02801643 record still lists
NCT02801643 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 0 interventions.
NCT02801643 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02801643 about?
NCT02801643 is a clinical study titled "The Impact of Reward-induced Dopamine Release on Functional Connectivity: a Combined PET/fMRI Study". The present study would be the first to investigate the relationship between reward- and or social stimuli-induced dopamine (DA) release and neural function using a combined PET/fMRI approach. Data from this project conducted in healthy subjects will provide preliminary data for a larger grant appli...
What is the current status of trial NCT02801643?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2016-06. Estimated completion is 2017-12.
What conditions does trial NCT02801643 study?
This clinical trial studies the following conditions: Healthy.
Who is sponsoring clinical trial NCT02801643?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02801643 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02801643's enrollment target sits among peer trials
5 1085th of 1090 higher than 5 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia